Femara 2,5 mg Orifarm

Description

Undesirable effects

• Haematopoietic system: rarely – leukopenia.
• Immune system: frequency unknown – anaphylactic reactions.
• Metabolism: very common – hypercholesterolaemia; common – anorexia, increased appetite.
• Mental disorders: frequently – depression; rarely – anxiety (including nervousness), irritability.
• Nervous system: often – headache, dizziness; rarely – somnolence, insomnia, memory disturbances, sensory disturbances (including paresthesia, hypoaesthesia), taste perception disturbances, episodes of cerebral circulatory disturbances, carpal tunnel syndrome.
• Visual organs: rarely – cataracts, eye irritation, ‘blurred’ vision.
• Cardiovascular system: very common – seizure-like feeling of heat (“hot flashes”); common – increased blood pressure; rare – palpitations, tachycardia, coronary artery disease (including newly diagnosed or worsening existing angina, angina requiring surgical intervention, myocardial infarction, myocardial ischaemia), thrombophlebitis (including superficial and deep vein thrombophlebitis); rare – pulmonary embolism, arterial thrombosis, stroke, ischaemic attack.